Real-World Characteristics and Outcomes Among Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) and HER2 Mutations

被引：0
|
作者：
Bath, Christina [1 ]
Le, Xiuning [2 ]
Lovly, Christine M. [3 ]
Patil, Tejas [4 ]
Maruti, Sonia S. [5 ]
Stanhope, Stephen A. [5 ]
Herbert, Stephan [6 ]
Nagasaka, Misako [7 ,8 ,9 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Univ Colorado, Sch Med, Aurora, CO USA
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[7] Univ Calif Irvine, Sch Med, Orange, CA USA
[8] Chao Family Comprehens Canc Ctr, Orange, CA USA
[9] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.115
引用
收藏
页码：E49 / E50
页数：2
相关论文
共 50 条
  • [1] Real-world characteristics, treatment patterns and outcomes of patients with advanced HER2/ERBB2-mutant non-small cell lung cancer (NSCLC) in France and Germany
    Christopoulos, P.
    Girard, N.
    Zhang, L.
    Mbanya, Z.
    Dunton, K.
    Ali, A.
    Berktas, M.
    Delmastro, L.
    Struebing, A.
    Xiong, Y.
    Lay-Flurrie, S.
    Hindocha, P.
    Mehdikhanova, T.
    ANNALS OF ONCOLOGY, 2023, 34
  • [2] Real-World Outcomes Among Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
    Waterhouse, D.
    Iadeluca, L.
    Sura, S.
    Zhou, J.
    Wilner, K.
    Emir, B.
    Espirito, J.
    Bartolome, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S317 - S317
  • [3] Real-world clinical characteristics and treatment of advanced non-small cell lung cancer (NSCLC) patients in China
    Shi, Yuankai
    Zhang, Xin
    Wu, Gang
    Xu, Jianping
    He, Yong
    Wang, Dong
    Huang, Cheng
    Chen, Mingwei
    Yu, Ping
    Yu, Yan
    Li, Wei
    Li, Qi
    Hu, Xiao-hua
    Sun, Guofang
    Li, Yulin
    Bu, Lilian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] The patients' characteristics and the clinical outcomes in advanced non-small cell lung cancer patients with HER2 mutation
    Liao, Pei-Ya
    Huang, Yen-Hsiang
    Hsu, Kuo-Hsuan
    Tseng, Jeng-Sen
    Lee, Po-Hsin
    Yang, Tsung-Ying
    RESPIROLOGY, 2023, 28 : 297 - 297
  • [5] Molecular Characteristics of HER2 Mutations in Non-Small Cell Lung Cancer
    Wei, X.
    Gao, X.
    Zhang, X.
    Chen, Z.
    Wu, Y.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S848 - S849
  • [6] Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations
    Chen, Chi-Han
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Hsu, Ping-Chih
    Wu, Chiao-En
    ANTICANCER RESEARCH, 2022, 42 (04) : 2145 - 2157
  • [7] HER2 mutations in Chinese patients with non-small cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    Shi, Zhiyong
    Zhao, Jun
    Zhang, Yiping
    ONCOTARGET, 2016, 7 (47) : 78152 - 78158
  • [8] HER2 Mutations in Chinese Patients with Non-Small Cell Lung Cancer
    Song, Zhengbo
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S494 - S495
  • [9] Immunotherapy for non-small cell lung cancer with EGFR or HER2 exon 20 insertion mutations: a real-world analysis
    Zhang, Mai
    Huang, Qian
    Yu, Min
    Xue, Jianxin
    Huang, Meijuan
    Lu, You
    Zhang, Yan
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (04) : 797 - 807
  • [10] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
12345